Evidence map›Paper›PMID 30543693›Full record

ArticlePloS one2018

Implementing the package of CDC and WHO recommended linkage services: Methods, outcomes, and costs of the Bukoba Tanzania Combination Prevention Evaluation peer-delivered, linkage case management program, 2014-2017.

Duncan MacKellar, Haruka Maruyama, Oscar Ernest Rwabiyago, Claire Steiner, Haddi Cham, Omari Msumi, Rachel Weber, Gerald Kundi, Chutima Suraratdecha, Tewodaj Mengistu and 9 more

Erratum issuedAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Duncan MacKellarDivision of Global HIV and TB, National Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.ORCID 0000-0001-8217-9881
Haruka MaruyamaICAP at Columbia University, Dar es Salaam, Tanzania.
Oscar Ernest RwabiyagoCenters for Disease Control and Prevention, Dar es Salaam, Tanzania.
Claire SteinerICAP at Columbia University, Dar es Salaam, Tanzania.
Haddi ChamDivision of Global HIV and TB, National Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Omari MsumiICAP at Columbia University, Dar es Salaam, Tanzania.
Rachel WeberCTS Global, Inc., assigned to Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.
Gerald KundiICAP at Columbia University, Dar es Salaam, Tanzania.
Chutima SuraratdechaDivision of Global HIV and TB, National Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Tewodaj MengistuDivision of Global HIV and TB, National Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Johnita ByrdICF International, Atlanta, Georgia.
Sherri PalsDivision of Global HIV and TB, National Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Eliufoo ChuriICAP at Columbia University, Dar es Salaam, Tanzania.
Caitlin Madevu-MatsonICAP at Columbia University, New York, New York, United States of America.
Kokuhumbya KazauraCenters for Disease Control and Prevention, Dar es Salaam, Tanzania.
Fernando MoralesICAP at Columbia University, Dar es Salaam, Tanzania.
Thomas RutachunzibwaMoHCDGEC, Bukoba, Tanzania.
Jessica JustmanICAP at Columbia University, New York, New York, United States of America.
Anath RwebemberaNational AIDS Control Program, MoHCDGEC, Dar es Salaam, Tanzania.

Funding

PEPFAR
6 · The paper itself

Abstract

Although several studies have evaluated one or more linkage services to improve early enrollment in HIV care in Tanzania, none have evaluated the package of linkage services recommended by the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO). We describe the uptake of each component of the CDC/WHO recommended package of linkage services, and early enrollment in HIV care and antiretroviral therapy (ART) initiation among persons with HIV who participated in a peer-delivered, linkage case management (LCM) program implemented in Bukoba, Tanzania, October 2014 -May 2017. Of 4206 participants (88% newly HIV diagnosed), most received recommended services including counseling on the importance of early enrollment in care and ART (100%); escort by foot or car to an HIV care and treatment clinic (CTC) (83%); treatment navigation at a CTC (94%); telephone support and appointment reminders (77% among clients with cellphones); and counseling on HIV-status disclosure and partner/family testing (77%), and on barriers to care (69%). During three periods with different ART-eligibility thresholds [CD4<350 (Oct 2014 -Dec 2015, n = 2233), CD4≤500 (Jan 2016 -Sept 2016, n = 1221), and Test & Start (Oct 2016 -May 2017, n = 752)], 90%, 96%, and 97% of clients enrolled in HIV care, and 47%, 67%, and 86% of clients initiated ART, respectively, within three months of diagnosis. Of 463 LCM clients who participated in the last three months of the rollout of Test & Start, 91% initiated ART. Estimated per-client cost was $44 United States dollars (USD) for delivering LCM services in communities and facilities overall, and $18 USD for a facility-only model with task shifting. Well accepted by persons with HIV, peer-delivered LCM services recommended by CDC and WHO can achieve near universal early ART initiation in the Test & Start era at modest cost and should be considered for implementation in facilities and communities experiencing <90% early enrollment in ART care.

Indexed as

Antiretroviral Therapy, Highly ActiveCase ManagementAdultCD4 Lymphocyte CountCenters for Disease Control and Prevention, U.S.CounselingFemaleHIV InfectionsHumansMalePeer GroupProgram EvaluationTanzaniaUnited StatesWorld Health Organization

Identifiers

PMID30543693
PMCPMC6292635

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.